GU Oncology Symposium starts today in San Francisco

So the annual ASCO Genitourinary Cancers Symposium will start this morning in San Francisco. For those who are interested, the abstracts of all the presentations to be give (oral and posters) are already freely available on line. There are “only” about 770 of them in total (but they aren’t all about prostate cancer). Click here to get all the details!

Next patient conference near Cincinnati, OH, in April 2020

On Saturday, April 18, 2020, Prostate Cancer International (PCaI) will collaborate with the local chapter of the Cancer Support Community to hold a patient and family educational conference on prostate cancer near Cincinnati, OH. … READ MORE …

InfoLink information hiatus

Over the past month there have been no new postings to this web site. Your sitemaster apologizes for this hiatus.

The reasons are complex and include the sitemaster’s personal health status (nothing really serious but distinctly debilitating) and other business and personal pressures.

The current goal is to start to get things back on track as on Monday, November 18, so please be patient with us for just a couple more days.

Gone but by no means forgotten

It is with great regret that we must report the demise — last Saturday — of Dr. Gerald (“Gerry”) Chodak — formerly a professor of urology at the University of Chicago Pritzker School of Medicine. … READ MORE …

The APCCC in Basel, Switzerland: where to get the details

Our friends at UroToday are now making available the individual presenters’ slides and other materials from the 3rd Advanced Prostate Cancer Consensus Conference (APCCC) that ended in Basel, Switzerland, last Saturday, as well as detailed interviews on specific topics that were recorded at the meeting. … READ MORE …

Important upcoming conferences and educational events

There are a number of significant upcoming conferences and patient education events that readers may want to be aware of happening from now through to the end of the year (inclusive of the next patient meeting coordinated by Prostate Cancer International): … READ MORE …

Conflicts of interest always present problems (to some degree)

As our friend Howard Wolinsky continues his journalistic exploits into the world of prostate cancer, he has (almost inevitably) come across an issue of “conflicts of interest”, … READ MORE …

A chance for US patients to “speak to power”

The roles of patients, patient advocates, and other members of the public in decision-making about the research that is funded by NIH and other agencies here in America is sadly somewhat limited, … READ MORE …

Early data suggest 18F-DCFPyL PET/CT scans can change patient management

A media release issued yesterday by Progenics Pharmaceuticals states that the investigational imaging agent 18F-DCFPyL changed physician behavior in the management of biochemically recurrent prostate cancer in > 65 percent of patients. … READ MORE …

Depression in men on ADT

Depression is relatively common among men with prostate cancer. Indeed, it may be a lot more common than we can currently document. … READ MORE …

Long-term follow-up data from LATITUDE trial

Long-term follow-up data from the LATITUDE trial have now been published by Fizazi et al. in Lancet Oncology. … READ MORE …

Germline genetic testing for men with prostate cancer

In this week’s Journal of Clinical Oncology, there is a full-text article in the “Comments and Controversies” section entitled … READ MORE …

The use of the word “survivor” can arouse strong feelings

In his latest epistle on living with cancer on MedPage Today, Howard Wolinsky addresses what he has come to understand is a very sensitive topic. … READ MORE …

Does TRT really delay biochemical recurrence after radical prostatectomy (in selected patients)?

Some data presented a few weeks ago at the annual meeting of the European Association for Urology appear to have surprised not only the study’s authors, but pretty much everyone else as well. … READ MORE …

Agent Orange and prostate cancer-specific survival on ADT

A newly published article in this month’s Journal of Urology has suggested that being exposed to Agent Orange and getting prostate cancer comes with better overall survival data than if one gets prostate cancer some other way. … READ MORE …